BSE:500298

Stock Analysis Report

National Peroxide

Executive Summary

National Peroxide Limited manufactures and sells peroxygens in India.

Snowflake

Fundamentals

Flawless balance sheet, good value and pays a dividend.

Share Price & News

How has National Peroxide's share price performed over time and what events caused price changes?


Latest Share Price and Events


Market Performance


7 Day Return

14.5%

500298

1.9%

IN Chemicals

3.2%

IN Market


1 Year Return

-53.8%

500298

17.2%

IN Chemicals

5.6%

IN Market

Return vs Industry: 500298 underperformed the Indian Chemicals industry which returned 17.2% over the past year.

Return vs Market: 500298 underperformed the Indian Market which returned 5.6% over the past year.


Shareholder returns

500298IndustryMarket
7 Day14.5%1.9%3.2%
30 Day11.2%8.6%6.0%
90 Day10.4%11.6%2.0%
1 Year-52.2%-53.8%20.2%17.2%7.8%5.6%
3 Year132.2%114.6%37.5%32.0%22.6%16.3%
5 Year308.9%269.6%130.6%112.8%43.1%29.6%

Price Volatility Vs. Market

How volatile is National Peroxide's share price compared to the market and industry in the last 5 years?


Simply Wall St News

Valuation

Is National Peroxide undervalued compared to its fair value and its price relative to the market?

19.1%

Undervalued compared to fair value


Share Price vs. Fair Value

Undervalued: 500298 (₹2125.15) is trading below our estimate of fair value (₹2627.46)

Significantly Undervalued: 500298 is trading below fair value, but not by a significant amount.


Price To Earnings Ratio

PE vs Industry: 500298 is good value based on its PE Ratio (9.8x) compared to the Chemicals industry average (10.8x).

PE vs Market: 500298 is good value based on its PE Ratio (9.8x) compared to the Indian market (13.3x).


Price to Earnings Growth Ratio

Low PEG Ratio: Insufficient data to calculate 500298's PEG Ratio to determine if it is good value.


Price to Book Ratio

PB vs Industry: 500298 is good value based on its PB Ratio (1x) compared to the IN Chemicals industry average (1.1x).


Next Steps

Future Growth

How is National Peroxide forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?

11.1%

Forecasted annual earnings growth


Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: 500298's forecast earnings growth (11.1% per year) is above the savings rate (7.6%).

Earnings vs Market: 500298's earnings (11.1% per year) are forecast to grow slower than the Indian market (18.3% per year).

High Growth Earnings: 500298's earnings are forecast to grow, but not significantly.

Revenue vs Market: Insufficient data to determine if 500298's revenue is forecast to grow faster than the Indian market.

High Growth Revenue: Insufficient data to determine if 500298's revenue is forecast to grow faster than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

High Future ROE: Insufficient data to determine if 500298's Return on Equity is forecast to be high in 3 years time


Next Steps

Past Performance

How has National Peroxide performed over the past 5 years?

47.0%

Historical annual earnings growth


Earnings and Revenue History


Past Earnings Growth Analysis

Earnings Trend: 500298's earnings have grown significantly by 47% per year over the past 5 years.

Accelerating Growth: 500298's earnings growth over the past year (13%) is below its 5-year average (47% per year).

Earnings vs Industry: 500298 earnings growth over the past year (13%) exceeded the Chemicals industry 9.9%.


Return on Equity

High ROE: 500298's Return on Equity (10.6%) is considered low.


Return on Assets

ROA vs Industry: 500298's Return on Assets is below or equal to the Chemicals industry average last year.


Return on Capital Employed

ROCE Improving: 500298's Return on Capital Employed has declined over the past 3 years.


Next Steps

Financial Health

How is National Peroxide's financial position?


Financial Position Analysis

Short Term Liabilities: 500298's short term assets (₹3.3B) exceeds its short term liabilities (₹585.4M)

Long Term Liabilities: 500298's short term assets (3.3B) exceeds its long term liabilities (1.1B)


Debt to Equity History and Analysis

Debt Level: 500298's debt to equity ratio (7.3%) is considered satisfactory

Reducing Debt: 500298's debt to equity ratio has reduced from 10.2% to 7.3% over the past 5 years.

Debt Coverage: 500298's debt is well covered by operating cash flow (171.9%).

Interest Coverage: 500298 earns more interest than it pays, so coverage of interest payments is not a concern.


Balance Sheet

Inventory Level: 500298 has a high level of physical assets or inventory.

Debt Coverage by Assets: 500298's debt is covered by short term assets (assets are 3.865600x debt).


Next Steps

Dividend

What is National Peroxide's current dividend yield, its reliability and sustainability?

3.06%

Current Dividend Yield


Dividend Yield vs Market

company3.1%marketbottom25%0.6%markettop25%2.4%industryaverage0.9%forecastin3Yearsn/a

Current dividend yield vs market & industry


Stability and Growth of Payments

Notable Dividend: 500298's dividend (3.06%) is higher than the bottom 25% of dividend payers in the Indian market (0.59%).

High Dividend: 500298's dividend (3.06%) is in the top 25% of dividend payers in the Indian market (2.43%)

Stable Dividend: 500298's dividend payments have been volatile in the past 10 years.

Growing Dividend: 500298's dividend payments have increased over the past 10 years.


Current Payout to Shareholders

Dividend Coverage: With its reasonably low payout ratio (30%), 500298's dividend payments are well covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: Insufficient data to determine if a dividend will be paid in 3 years and that it will be covered by earnings.


Next Steps

Management

What is the CEO of National Peroxide's salary, the management and board of directors tenure and is there insider trading?

0.8yrs

Average management tenure


CEO

Suresh Khurana (65yo)

1.8yrs

Tenure

₹22,061,560

Compensation

Mr. Suresh Khurana serves as Chief Executive Officer and Director at National Peroxide Ltd. He serves as the Chief Executive Officer of PSF at The Bombay Dyeing and Manufacturing Company Limited. 


CEO Compensation Analysis

Compensation vs. Market: Insufficient data to establish whether Suresh's total compensation is reasonable compared to companies of similar size in the Indian market.

Compensation vs Earnings: Insufficient data to compare Suresh's compensation with company performance.


Management Age and Tenure

0.8yrs

Average Tenure

Experienced Management: 500298's management team is not considered experienced ( 0.8 years average tenure), which suggests a new team.


Board Age and Tenure

5.1yrs

Average Tenure

64yo

Average Age

Experienced Board: 500298's board of directors are considered experienced (5.1 years average tenure).


Insider Trading

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Recent Insider Transactions

Buy₹10,535,66223 Nov 18
Ness Wadia
EntityIndividual
Role
Chairman of the Board
Non Independent Non-Executive Chairman
Shares2,400
Max Price₹4,394.34
Buy₹2,363,19922 Nov 18
Ness Wadia
EntityIndividual
Role
Chairman of the Board
Non Independent Non-Executive Chairman
Shares550
Max Price₹4,312.12
Buy₹2,382,26514 Nov 18
Ness Wadia
EntityIndividual
Role
Chairman of the Board
Non Independent Non-Executive Chairman
Shares500
Max Price₹4,764.53
Buy₹1,510,91309 Nov 18
Ness Wadia
EntityIndividual
Role
Chairman of the Board
Non Independent Non-Executive Chairman
Shares300
Max Price₹5,036.38
Buy₹4,103,27106 Nov 18
Ness Wadia
EntityIndividual
Role
Chairman of the Board
Non Independent Non-Executive Chairman
Shares850
Max Price₹5,002.35

Ownership Breakdown


Management Team

  • Suresh Khurana (65yo)

    CEO & Director

    • Tenure: 1.8yrs
    • Compensation: ₹22.06m
  • Vinayak Pujar

    General Manager of Marketing

    • Tenure: 1.8yrs
  • Y. Parkar

    Vice President of Technical & Projects

    • Tenure: 0yrs
  • Conrad Fernandes (52yo)

    Chief Financial Officer

    • Tenure: 0.8yrs
  • Hasit Dangi

    Vice President of Operations & Quality Assurance

    • Tenure: 1.8yrs
  • Chandukumar Parmar

    Company Secretary & Compliance Officer

    • Tenure: 0.7yrs
  • Ajay Bhardwaj

    Chief Human Resource Officer

    • Tenure: 0.8yrs
  • Rajeev Pradhan

    Chief Information Officer

    • Tenure: 0.8yrs

Board Members

  • Sethumadhava Ragothaman (73yo)

    Independent Non-Executive Director

    • Tenure: 6.2yrs
    • Compensation: ₹1.40m
  • Ness Wadia (48yo)

    Non Independent Non-Executive Chairman

    • Tenure: 8.5yrs
    • Compensation: ₹4.39m
  • Rajesh Batra (64yo)

    Independent Non-Executive Director

    • Tenure: 13.8yrs
    • Compensation: ₹2.25m
  • Minnie Bodhanwala (56yo)

    Non- Independent Non-Executive Director

    • Tenure: 4yrs
    • Compensation: ₹700.70k
  • Suresh Khurana (65yo)

    CEO & Director

    • Tenure: 1.8yrs
    • Compensation: ₹22.06m
  • Viraf Mehta (64yo)

    Additional Non-Executive & Independent Director

    • Tenure: 0.3yrs

Company Information

National Peroxide Limited's company bio, employee growth, exchange listings and data sources


Key Information

  • Name: National Peroxide Limited
  • Ticker: 500298
  • Exchange: BSE
  • Founded: 1954
  • Industry: Commodity Chemicals
  • Sector: Materials
  • Market Cap: ₹12.213b
  • Shares outstanding: 5.75m
  • Website: https://www.naperol.com

Number of Employees


Location

  • National Peroxide Limited
  • C-1, Wadia International Center
  • Pandurang Budhkar Marg
  • Mumbai
  • Maharashtra
  • 400025
  • India

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
500298BSE (Mumbai Stock Exchange)YesEquity SharesININRJan 2002

Biography

National Peroxide Limited manufactures and sells peroxygens in India. It offers hydrogen peroxide that is used in various industries for bleaching, chemical synthesis, environmental control/effluent treatm ...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2019/10/19 12:43
End of Day Share Price2019/10/18 00:00
Earnings2019/06/30
Annual Earnings2019/03/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.